reported side effects of azathioprine
infection
nausea
leukopenia
vomiting
comprehensive list of adverse effects
principal
serious toxic effects of azathioprine
risk of secondary infection
malignancy
frequency
severity of side effects
dose
duration of azathioprine
underlying disease
concomitant therapies
hematologic toxicities
neoplasia
renal homograft recipients
patients
using azathioprine for rheumatoid arthritis
depression of bone marrow function
leukopeniacommon
anemia
thrombocytopeniarare
agranulocytosis
aplastic anemia
erythroid hypoplasia
megaloblastic anemia
pancytopeniafrequency
bleeding
mean
corpuscular volume
red cell hemoglobin content
bone marrow suppression
dose
common cause for dosage reductions
leukopenia
degree
renal homograft recipients
rheumatoid arthritis patients
leukopenia
mm
l
renal homograft recipients
rheumatoid arthritis patients
data
increased risk of bone marrow aplasia in patients
absent thiopurine methyltransferase
tpmt
activity
patients with low tpmt activity
increase
thioguanine nucleotide
tgn
concentrations
cytotoxic metabolite
purine synthesis
death
pancytopenia
patients with absent tpmt activity
receiving azathioprine
bone marrow aplasia
patients with normal tpmt activity
year-old male with pompholyx
deficiency of erythrocyte thiopurine methyltransferase
pancytopenia
azathioprine therapy
weeks
starting azathioprine mg per day
full blood count
routine monitoring
moderate pancytopenia
azathioprine was discontinued.
days
hospital with malaise
lethargy
deterioration in blood count
blood
platelet transfusions
days
modest improvement in peripheral blood count
nausea
vomitinguncommon
diarrhea
pancreatitis
steatorrhearare
colitis
transplant recipients
diverticulitis
intestinal perforation
transplant recipients
gastrointestinal ulcers
transplant recipients
intestinal hemorrhage
transplant recipients
necrosis
transplant recipients
severe diarrhea
inflammatory bowel disease patients
frequency
severe villus
sores in the mouth
lips
gastrointestinal side effects
first few months of therapy
year-old man
severe small-bowel villus atrophy
chronic diarrhea
starting azathioprine mg per day
diarrhea
weeks after azathioprine discontinuation
mucosal biopsies at months post azathioprine discontinuation
complete reversal of severe duodenal villus atrophy
complications
colitis
diverticulitis
bowel perforation
transplant patients
concomitant high-dose corticosteroid therapy
pancreatitis
organ recipients
patients with crohn
disease
been case reports of patients with symptoms
viral gastroenteritis
nausea
vomiting
diarrhea
fever
occurring hours after a single dose of azathioprine
cervical cancer
kaposi
sarcoma
lymphoma
squamous cell carcinoma of the skin
vulval cancer
renal homograft patients
lymphoproliferative diseases after transplantationrare
melanoma
non-kaposi
sarcomavery
acute myeloid leukemia
myelodysplastic syndromesfrequency
hepatosplenic t-cell lymphoma
increased risk of cancer
azathioprine
other immunosuppressive agents
renal transplant patients
higher risk
developing
developing lymphoproliferative disorders
lymphomas
leukemia
solid tumors
receiving azathioprine
transplant patients
rheumatoid arthritis
multiple immunosuppressants
true risk of neoplasia
azathioprine
small increase in the risk of epstein-barr virus-positive lymphoma
study of patients with inflammatory bowel disease
azathioprine
majority
reported cases of hepatosplenic t-cell lymphoma
bee in patients with crohn
disease
ulcerative colitis
young adult males
hepatic dysfunction
including cholestasis
destructive cholangitis
peliosis hepatitis
perisinusoidal fibrosis
nodular regenerative hyperplasia
organ transplant recipients
hepatotoxicity
including elevation of serum alkaline phosphatase
bilirubin
serum transaminasesrare
hepatic veno-occlusive disease
life-threatening hepatic damagefrequency
acute focal hepatocellular necrosis
sinusoidal dilatation
hepatotoxicity
months of therapy
patients
requiring immunosuppression
following transplant
patients
requiring therapy for rheumatoid arthritis
hepatotoxicity
cholestasis
acute focal hepatocellular necrosis
reversible following discontinuation of azathioprine therapy
permanent hepatic damage
cirrhosis
perisinusoidal fibrosis
hepatic peliosis
sinusoidal dilatation
veno-occlusive disease
several cases of nodular regenerative hyperplasia of the liver
case of destructive cholangitis
veno-occlusive disease of the hepatic veins
unknown mechanism
males
portal hypertension
poor prognosis
numerous fatalities
permanent discontinuation of azathioprine therapy
hepatic veno-occlusive disease
year-old man
jaundice
diffuse abdominal pain
months after the start of azathioprine mg/kg/day
biopsy reports
destruction of the bile ducts
destructive cholangitis
discontinuation of azathioprine
abdominal pain
days
liver function tests
normal values weeks
hypersensitivity reactions
stevens-johnson syndrome
toxic epidermal necrolysisvery
hypersensitivity reactions with fatal outcome
idiosyncratic manifestations of hypersensitivity
general malaise
headache
dizziness
nausea
vomiting
diarrhea
fever
rigors
exanthema
rash
vasculitis
myalgia
arthralgia
hypotension
renal dysfunction
hepatic dysfunction
cardiac dysrhythmia
cholestasis
rhabdomyolysis
part of an azathioprine hypersensitivity syndrome
least cases of erythema nodosum
cases of pustules
case of contact dermatitis
erythema nodosum
pustules
clinical activity of inflammatory bowel disease
relapse of such lesions
rechallenge
hypothesis of hypersensitivity
pharmacological manifestations
azathioprine
occurrence of hypersensitivity reactions
cases of atrial fibrillation
case
patient with ulcerative colitis
causality
year-old male with steroid-dependent ulcerative colitis
atrial fibrillation
azathioprine therapy
drug
been started years
few months because the patient
palpitations
lipothymia
nausea
vomiting
rechallenge with mg of azathioprine
patient
general malaise
nausea
vomiting
ecg
atrial fibrillation
patient
symptoms
azathioprine-induced hypotension
dose
signs
symptoms of hypersensitivity
hypotension
intravenous fluids
hypersensitivity
corticosteroids
hypotension
including
cardiogenic shockfrequency
atrial fibrillation
alopecia
patients on azathioprine monotherapy
combination with other immunosuppressants
side effect
ongoing therapy
female patient
skin peeling syndrome
months after the dosage of azathioprine
mg
skin lesions
resolved days after drug withdrawal
excess sun exposure
pale skin types
duration of allograft
important risk factors in the development of skin lesions
alopeciafrequency
exacerbation of dermatomyositis
rash
sweet
syndrome
acute febrile neutrophilic dermatosis
hematuria
azathioprine-induced crystalluria
bacterial infections
transplant recipients
receiving
receiving other immunosuppressants
susceptibility
infection in patients with inflammatory bowel diseaseuncommon
bacterial infections
other indications
frequency
protozoal
opportunistic infections
including reactivation of latent infections
susceptibility
varicella
herpes zoster
progressive multifocal leukoencephalopathy
anorexiafrequency
negative nitrogen balance
frequency
arthralgias
myalgias
frequency
alterations in sense of smell
taste
exacerbation of myasthenia gravis
meningitis
frequency
cmv retinitis
patient with systemic lupus erythematosus
end-stage renal disease
cmv retinitis
azathioprine therapy
immunosuppressive therapy
role in the development of cmv retinitis in this population
patient
discontinuation of azathioprine
lowering of the corticosteroid dose
systemic administration of ganciclovir
elevation in serum creatinine
bun
oliguria
hypotension
treatment with intravenous hydration
steroids
cases of hematuria
azathioprine-induced crystalluria
high urine output
reduction in the incidence of chronic allograft nephropathy
extended follow-up
years
patients
n =-rrb-
randomized trial
conversion from cyclosporine
azathioprine as early
months after renal transplantation
wegener
granulomatosis
rapid progression of renal failure within days
starting azathioprine for vasculitis
creatinine
mcmol/l at the time of presentation
acute tubulointerstitial nephritis
active glomerulonephritis
renal biopsy
renal function
improving by day post-admission
month
serum creatinine
mcmol/l
reasonable renal function
months
creatinine of mcmol/l with no clinical evidence of recurrent interstitial nephritis
frequency
acute interstitial nephritis
chronic allograft nephropathy
elevation in serum creatinine
bun
oliguria
reversible interstitial pneumonitis
review
rare cases of azathioprine-associated interstitial pneumonitis
progression from alveolitis
pulmonary fibrosis
been reports of fungal
protozoal
uncommon bacterial infections
patients
receiving azathioprine
frequency
delayed wound healing
fatigue
fever
malaise
oral lesions
intravenous powder for solution
black, tarry stools
bleeding gums
blood in the urine
stools
chest pain
cough or hoarseness
fever or chills
side pain
difficult urination
red spots on the skin
shortness of breath
sore throat
sores
ulcers
white spots on the lips
mouth
swollen glands
unusual bleeding
bruising
unusual tiredness
weakness
stomach pain
tenderness
clay-colored stools
dark urine
decreased appetite
fast heartbeat
fever (sudden)
headaches
itching
loss of appetite
muscle
joint pain
nausea
vomiting
diarrhea
redness
blisters on the skin
swelling of the feet
lower legs
unusual feeling of discomfort
illness
yellow eyes
skin
stomach cramps
diarrhea
difficulty with breathing
difficulty with moving
fat in the stool
general feeling of illness
pale skin
sores on the skin
sudden loss of weight
troubled breathing with movement
weight loss
nausea
vomiting
swollen joints
hair loss
thinning of the hair